Is Precipio Inc (PRPO) overvalued? · rev $18.5M
Precipio Inc (PRPO) is a diagnostics & research company listed on NASDAQ.
This page asks whether Precipio Inc (PRPO) looks expensive on cached numbers — not a short thesis.
Latest reported PRPO revenue for 2024-12-31 was $18.5M. Net income was -$4.3M. Revenue was up 21.9% from 2023-12-31 to 2024-12-31. PRPO currently screens at market cap $39.0M.
PRPO currently screens at market cap $39.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PRPO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PRPO stock page for the full model, not this heading.
Not investment advice.